MediBeacon is a medical technology company specializing in advancement of fluorescent tracer agents and transdermal detection. MediBeacon’s use of fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable measurement of organ function.
MediBeacon is in the process of completing enrollment in the global TGFR Pivotal Study at US and China based clinical sites. The TGFR is designed to provide clinicians measurement of Glomerular Filtration Rate (GFR) or kidney function at the point of care with no need for blood sampling or urine collection.
Additional Info
First-time Exhibitor:
No